{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T23:28:37Z","timestamp":1790292517551,"version":"4.1.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2017,3,2]],"date-time":"2017-03-02T00:00:00Z","timestamp":1488412800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2017,3,2]],"date-time":"2017-03-02T00:00:00Z","timestamp":1488412800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The energy sensor AMP-activated protein kinase (AMPK) is crucial for energy homeostasis. Recent studies have revealed that AMPK is involved in various energy-intensive pathological processes such as inflammation and apoptosis. The physiological functions of hepatic AMPK have been well studied, but the pathological significance of AMPK in liver disorders remains largely unknown. In the present study, the phosphorylation status and the roles of AMPK were investigated in mice with lipopolysaccharide (LPS)\/<jats:sc>d<\/jats:sc>-galactosamine (D-Gal)-induced fulminant hepatitis. The experimental data indicated that the phosphorylation of hepatic AMPK increased in mice with LPS\/D-Gal-induced fulminant hepatitis. Pretreatment with the AMPK inhibitor compound C enhanced the early production of pro-inflammatory cytokines but suppressed the late activation of the caspase cascade, reduced the number of TUNEL-positive cells, decreased the elevation of aminotransferases, alleviated the histological abnormalities and improved the survival rate of LPS\/D-Gal-insulted mice. Pretreatment with compound C suppressed LPS\/D-Gal-induced phosphorylation of JNK. Inhibition of JNK alleviated LPS\/D-Gal-induced liver injury, but the level of p53 remained unchanged in mice exposed to LPS\/D-Gal. Post-insult treatment with the AMPK activator A-769662 further increased the phosphorylation levels of AMPK and JNK, enhanced hepatocyte apoptosis and deteriorated liver injury, all of these effects could be reversed by co-administration of the AMPK inhibitor or JNK inhibitor. Interestingly, post-insult treatment with the AMPK inhibitor also resulted in beneficial outcomes. These data suggested that AMPK might be a late detrimental factor in LPS\/D-Gal-induced hepatitis via potentiating JNK-dependent hepatocyte apoptosis and AMPK might become a pharmacological target for the intervention of fulminant hepatitis.<\/jats:p>","DOI":"10.1038\/cddis.2017.62","type":"journal-article","created":{"date-parts":[[2017,3,2]],"date-time":"2017-03-02T13:43:58Z","timestamp":1488462238000},"page":"e2637-e2637","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":36,"title":["Endogenous AMPK acts as a detrimental factor in fulminant hepatitis via potentiating JNK-dependent hepatocyte apoptosis"],"prefix":"10.1038","volume":"8","author":[{"given":"Kai","family":"Hu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianqiong","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Ai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pu","family":"Ge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,3,2]]},"reference":[{"key":"BFcddis201762_CR1","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1038\/nature11862","volume":"493","author":"LA O'Neill","year":"2013","unstructured":"O'Neill LA, Hardie DG . Metabolism of inflammation limited by AMPK and pseudo-starvation. Nature 2013; 493: 346\u2013355.","journal-title":"Nature"},{"key":"BFcddis201762_CR2","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1016\/j.cmet.2014.09.013","volume":"20","author":"DG Hardie","year":"2014","unstructured":"Hardie DG . AMPK\u2014sensing energy while talking to other signaling pathways. Cell Metab 2014; 20: 939\u2013952.","journal-title":"Cell Metab"},{"key":"BFcddis201762_CR3","doi-asserted-by":"publisher","first-page":"3723","DOI":"10.1111\/febs.12364","volume":"280","author":"P Sanz","year":"2013","unstructured":"Sanz P, Rubio T, Garcia-Gimeno MA . AMPKbeta subunits: more than just a scaffold in the formation of AMPK complex. FEBS J 2013; 280: 3723\u20133733.","journal-title":"FEBS J"},{"key":"BFcddis201762_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ceb.2014.09.004","volume":"33","author":"DG Hardie","year":"2015","unstructured":"Hardie DG . AMPK: positive and negative regulation, and its role in whole-body energy homeostasis. Curr Opin Cell Biol 2015; 33: 1\u20137.","journal-title":"Curr Opin Cell Biol"},{"key":"BFcddis201762_CR5","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.tcb.2015.10.013","volume":"26","author":"DG Hardie","year":"2016","unstructured":"Hardie DG, Schaffer BE, Brunet A . AMPK: an energy-sensing pathway with multiple inputs and outputs. Trends Cell Biol 2016; 26: 190\u2013201.","journal-title":"Trends Cell Biol"},{"key":"BFcddis201762_CR6","doi-asserted-by":"publisher","first-page":"e245","DOI":"10.1038\/emm.2016.81","volume":"48","author":"SM Jeon","year":"2016","unstructured":"Jeon SM . Regulation and function of AMPK in physiology and diseases. Exp Mol Med 2016; 48: e245.","journal-title":"Exp Mol Med"},{"key":"BFcddis201762_CR7","doi-asserted-by":"publisher","first-page":"e224","DOI":"10.1038\/emm.2016.16","volume":"48","author":"J Kim","year":"2016","unstructured":"Kim J, Yang G, Kim Y, Kim J, Ha J . AMPK activators: mechanisms of action and physiological activities. Exp Mol Med 2016; 48: e224.","journal-title":"Exp Mol Med"},{"key":"BFcddis201762_CR8","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1111\/j.1748-1716.2009.01970.x","volume":"196","author":"B Viollet","year":"2009","unstructured":"Viollet B, Guigas B, Leclerc J, Hebrard S, Lantier L, Mounier R et al. AMP-activated protein kinase in the regulation of hepatic energy metabolism: from physiology to therapeutic perspectives. Acta Physiol 2009; 196: 81\u201398.","journal-title":"Acta Physiol"},{"key":"BFcddis201762_CR9","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.diabres.2005.12.011","volume":"73","author":"AY Viana","year":"2006","unstructured":"Viana AY, Sakoda H, Anai M, Fujishiro M, Ono H, Kushiyama A et al. Role of hepatic AMPK activation in glucose metabolism and dexamethasone-induced regulation of AMPK expression. Diabetes Res Clin Pract 2006; 73: 135\u2013142.","journal-title":"Diabetes Res Clin Pract"},{"key":"BFcddis201762_CR10","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1113\/jphysiol.2006.108506","volume":"574","author":"B Viollet","year":"2006","unstructured":"Viollet B, Foretz M, Guigas B, Horman S, Dentin R, Bertrand L et al. Activation of AMP-activated protein kinase in the liver: a new strategy for the management of metabolic hepatic disorders. J Physiol 2006; 574: 41\u201353.","journal-title":"J Physiol"},{"key":"BFcddis201762_CR11","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/S0140-6736(10)60274-7","volume":"376","author":"W Bernal","year":"2010","unstructured":"Bernal W, Auzinger G, Dhawan A, Wendon J . Acute liver failure. Lancet 2010; 376: 190\u2013201.","journal-title":"Lancet"},{"key":"BFcddis201762_CR12","doi-asserted-by":"publisher","first-page":"S67","DOI":"10.1002\/lt.21612","volume":"14","author":"P Ichai","year":"2008","unstructured":"Ichai P, Samuel D . Etiology and prognosis of fulminant hepatitis in adults. Liver Transplant 2008; 14: S67\u2013S79.","journal-title":"Liver Transplant"},{"key":"BFcddis201762_CR13","first-page":"147","volume":"10","author":"R Silverstein","year":"2004","unstructured":"Silverstein R . D-galactosamine lethality model: scope and limitations. J Endotoxin Res 2004; 10: 147\u2013162.","journal-title":"J Endotoxin Res"},{"key":"BFcddis201762_CR14","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1016\/j.jhep.2010.07.028","volume":"54","author":"A Pathil","year":"2011","unstructured":"Pathil A, Warth A, Chamulitrat W, Stremmel W . The synthetic bile acid-phospholipid conjugate ursodeoxycholyl lysophosphatidylethanolamide suppresses TNFalpha-induced liver injury. J Hepatol 2011; 54: 674\u2013684.","journal-title":"J Hepatol"},{"key":"BFcddis201762_CR15","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1002\/hep.25697","volume":"56","author":"J An","year":"2012","unstructured":"An J, Harms C, Lattig-Tunnemann G, Sellge G, Mandic AD, Malato Y et al. TAT-apoptosis repressor with caspase recruitment domain protein transduction rescues mice from fulminant liver failure. Hepatology 2012; 56: 715\u2013726.","journal-title":"Hepatology"},{"key":"BFcddis201762_CR16","doi-asserted-by":"publisher","first-page":"22352","DOI":"10.1074\/jbc.M115.667345","volume":"290","author":"VA Patel","year":"2015","unstructured":"Patel VA, Massenburg D, Vujicic S, Feng L, Tang M, Litbarg N et al. Apoptotic cells activate AMP-activated protein kinase (AMPK) and inhibit epithelial cell growth without change in intracellular energy stores. J Biol Chem 2015; 290: 22352\u201322369.","journal-title":"J Biol Chem"},{"key":"BFcddis201762_CR17","doi-asserted-by":"publisher","first-page":"1809","DOI":"10.1073\/pnas.1417636112","volume":"112","author":"S Eikawa","year":"2015","unstructured":"Eikawa S, Nishida M, Mizukami S, Yamazaki C, Nakayama E, Udono H . Immune-mediated antitumor effect by type 2 diabetes drug, metformin. Proc Natl Acad Sci USA 2015; 112: 1809\u20131814.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFcddis201762_CR18","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1177\/1753425915586231","volume":"21","author":"D Zhou","year":"2015","unstructured":"Zhou D, Ai Q, Lin L, Gong X, Ge P, Che Q et al. 5-Aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside-attenuates LPS\/D-Gal-induced acute hepatitis in mice. Innate Immunity 2015; 21: 698\u2013705.","journal-title":"Innate Immunity"},{"key":"BFcddis201762_CR19","doi-asserted-by":"publisher","first-page":"32549","DOI":"10.1074\/jbc.M706536200","volume":"282","author":"O Goransson","year":"2007","unstructured":"Goransson O, McBride A, Hawley SA, Ross FA, Shpiro N, Foretz M et al. Mechanism of action of A-769662, a valuable tool for activation of AMP-activated protein kinase. J Biol Chemy 2007; 282: 32549\u201332560.","journal-title":"J Biol Chemy"},{"key":"BFcddis201762_CR20","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1016\/j.chembiol.2014.03.006","volume":"21","author":"JW Scott","year":"2014","unstructured":"Scott JW, Ling N, Issa SM, Dite TA, O'Brien MT, Chen ZP et al. Small molecule drug A-769662 and AMP synergistically activate naive AMPK independent of upstream kinase signaling. Chem Biol 2014; 21: 619\u2013627.","journal-title":"Chem Biol"},{"key":"BFcddis201762_CR21","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1111\/joim.12268","volume":"276","author":"D Grahame Hardie","year":"2014","unstructured":"Grahame Hardie D . AMP-activated protein kinase: a key regulator of energy balance with many roles in human disease. J Intern Med 2014; 276: 543\u2013559.","journal-title":"J Intern Med"},{"key":"BFcddis201762_CR22","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1016\/j.freeradbiomed.2013.08.178","volume":"65","author":"SJ Kim","year":"2013","unstructured":"Kim SJ, Lee SM . NLRP3 inflammasome activation in D-galactosamine and lipopolysaccharide-induced acute liver failure: role of heme oxygenase-1. Free Radical Biol Med 2013; 65: 997\u20131004.","journal-title":"Free Radical Biol Med"},{"key":"BFcddis201762_CR23","doi-asserted-by":"publisher","first-page":"R1202","DOI":"10.1152\/ajpregu.2000.278.5.R1202","volume":"278","author":"M Nowak","year":"2000","unstructured":"Nowak M, Gaines GC, Rosenberg J, Minter R, Bahjat FR, Rectenwald J et al. LPS-induced liver injury in D-galactosamine-sensitized mice requires secreted TNF-alpha and the TNF-p55 receptor. Am J Physiol Regul Integr Comp Physiol 2000; 278: R1202\u2013R1209.","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"BFcddis201762_CR24","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/S0014-5793(02)03110-1","volume":"526","author":"D Meisse","year":"2002","unstructured":"Meisse D, Van de Casteele M, Beauloye C, Hainault I, Kefas BA, Rider MH et al. Sustained activation of AMP-activated protein kinase induces c-Jun N-terminal kinase activation and apoptosis in liver cells. FEBS Lett 2002; 526: 38\u201342.","journal-title":"FEBS Lett"},{"key":"BFcddis201762_CR25","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/j.molcel.2005.03.027","volume":"18","author":"RG Jones","year":"2005","unstructured":"Jones RG, Plas DR, Kubek S, Buzzai M, Mu J, Xu Y et al. AMP-activated protein kinase induces a p53-dependent metabolic checkpoint. Mol Cell 2005; 18: 283\u2013293.","journal-title":"Mol Cell"},{"key":"BFcddis201762_CR26","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.tips.2015.11.007","volume":"37","author":"B Dasgupta","year":"2016","unstructured":"Dasgupta B, Chhipa RR . Evolving lessons on the complex role of AMPK in normal physiology and cancer. Trends Pharmacolcal Sci 2016; 37: 192\u2013206.","journal-title":"Trends Pharmacolcal Sci"},{"key":"BFcddis201762_CR27","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/j.yjmcc.2016.01.001","volume":"91","author":"EP Daskalopoulos","year":"2016","unstructured":"Daskalopoulos EP, Dufeys C, Bertrand L, Beauloye C, Horman S . AMPK in cardiac fibrosis and repair: actions beyond metabolic regulation. J Mol Cell Cardiol 2016; 91: 188\u2013200.","journal-title":"J Mol Cell Cardiol"},{"key":"BFcddis201762_CR28","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1093\/hmg\/ddv513","volume":"25","author":"RP Vazquez-Manrique","year":"2016","unstructured":"Vazquez-Manrique RP, Farina F, Cambon K, Dolores Sequedo M, Parker AJ, Millan JM et al. AMPK activation protects from neuronal dysfunction and vulnerability across nematode, cellular and mouse models of Huntington's disease. Hum Mol Genet 2016; 25: 1043\u20131058.","journal-title":"Hum Mol Genet"},{"key":"BFcddis201762_CR29","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1038\/cdd.2013.21","volume":"20","author":"M Amir","year":"2013","unstructured":"Amir M, Zhao E, Fontana L, Rosenberg H, Tanaka K, Gao G et al. Inhibition of hepatocyte autophagy increases tumor necrosis factor-dependent liver injury by promoting caspase-8 activation. Cell Death Differ 2013; 20: 878\u2013887.","journal-title":"Cell Death Differ"},{"key":"BFcddis201762_CR30","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1111\/j.1582-4934.2004.tb00469.x","volume":"8","author":"WX Ding","year":"2004","unstructured":"Ding WX, Yin XM . Dissection of the multiple mechanisms of TNF-alpha-induced apoptosis in liver injury. J Cell Mol Med 2004; 8: 445\u2013454.","journal-title":"J Cell Mol Med"},{"key":"BFcddis201762_CR31","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1016\/j.fct.2011.11.009","volume":"50","author":"EC Liong","year":"2012","unstructured":"Liong EC, Xiao J, Lau TY, Nanji AA, Tipoe GL . Cyclooxygenase inhibitors protect D-galactosamine\/lipopolysaccharide induced acute hepatic injury in experimental micemodel. Food Chem Toxicol 2012; 50: 861\u2013866.","journal-title":"Food Chem Toxicol"},{"key":"BFcddis201762_CR32","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1139\/cjpp-2015-0230","volume":"94","author":"W Chen","year":"2016","unstructured":"Chen W, Lin YJ, Zhou XY, Chen H, Jin Y . Rosiglitazone protects rat liver against acute liver injury associated with the NF-kappaB signaling pathway. Can J Physiol Pharmacol 2016; 94: 28\u201334.","journal-title":"Can J Physiol Pharmacol"},{"key":"BFcddis201762_CR33","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1124\/jpet.103.062034","volume":"309","author":"NC Hoglen","year":"2004","unstructured":"Hoglen NC, Chen LS, Fisher CD, Hirakawa BP, Groessl T, Contreras PC . Characterization of IDN-6556 (3-[2-(2-tert-butyl-phenylaminooxalyl)-amino]-propionylamino]-4-oxo-5-(2,3,5,6-te trafluoro-phenoxy)-pentanoic acid): a liver-targeted caspase inhibitor. J Pharmacol Exp Therapeut 2004; 309: 634\u2013640.","journal-title":"J Pharmacol Exp Therapeut"},{"key":"BFcddis201762_CR34","doi-asserted-by":"crossref","first-page":"3480","DOI":"10.4049\/jimmunol.160.7.3480","volume":"160","author":"H Jaeschke","year":"1998","unstructured":"Jaeschke H, Fisher MA, Lawson JA, Simmons CA, Farhood A, Jones DA . Activation of caspase 3 (CPP32)-like proteases is essential for TNF-alpha-induced hepatic parenchymal cell apoptosis and neutrophil-mediated necrosis in a murine endotoxin shock model. J Immunol 1998; 160: 3480\u20133486.","journal-title":"J Immunol"},{"key":"BFcddis201762_CR35","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1517\/13543784.2012.696609","volume":"21","author":"IP Salt","year":"2012","unstructured":"Salt IP, Palmer TM . Exploiting the anti-inflammatory effects of AMP-activated protein kinase activation. Expert Opin Invest Drugs 2012; 21: 1155\u20131167.","journal-title":"Expert Opin Invest Drugs"},{"key":"BFcddis201762_CR36","doi-asserted-by":"publisher","first-page":"28897","DOI":"10.1074\/jbc.M804144200","volume":"283","author":"C Cao","year":"2008","unstructured":"Cao C, Lu S, Kivlin R, Wallin B, Card E, Bagdasarian A et al. AMP-activated protein kinase contributes to UV- and H2O2-induced apoptosis in human skin keratinocytes. J Biol Chem 2008; 283: 28897\u201328908.","journal-title":"J Biol Chem"},{"key":"BFcddis201762_CR37","doi-asserted-by":"publisher","first-page":"1680","DOI":"10.1016\/j.cellsig.2014.04.009","volume":"26","author":"Y Xu","year":"2014","unstructured":"Xu Y, Liu C, Chen S, Ye Y, Guo M, Ren Q et al. Activation of AMPK and inactivation of Akt result in suppression of mTOR-mediated S6K1 and 4E-BP1 pathways leading to neuronal cell death in in vitro models of Parkinson's disease. Cell Signal 2014; 26: 1680\u20131689.","journal-title":"Cell Signal"},{"key":"BFcddis201762_CR38","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.bbrc.2005.11.159","volume":"340","author":"Y Dagon","year":"2006","unstructured":"Dagon Y, Avraham Y, Berry EM . AMPK activation regulates apoptosis, adipogenesis, and lipolysis by eIF2alpha in adipocytes. Biochem Biophys Res Commun 2006; 340: 43\u201347.","journal-title":"Biochem Biophys Res Commun"},{"key":"BFcddis201762_CR39","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1134\/S0006297915020017","volume":"80","author":"DS Novikova","year":"2015","unstructured":"Novikova DS, Garabadzhiu AV, Melino G, Barlev NA, Tribulovich VG . AMP-activated protein kinase: structure, function, and role in pathological processes. Biochemistry (Mosc) 2015; 80: 127\u2013144.","journal-title":"Biochemistry (Mosc)"},{"key":"BFcddis201762_CR40","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1016\/j.bbrc.2008.04.003","volume":"370","author":"YM Lee","year":"2008","unstructured":"Lee YM, Uhm KO, Lee ES, Kwon J, Park SH, Kim HS . AM251 suppresses the viability of HepG2 cells through the AMPK (AMP-activated protein kinase)-JNK (c-Jun N-terminal kinase)-ATF3 (activating transcription factor 3) pathway. Biochem Biophys Res Commun 2008; 370: 641\u2013645.","journal-title":"Biochem Biophys Res Commun"}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/cddis201762.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/cddis201762","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/cddis201762.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,22]],"date-time":"2023-08-22T12:49:06Z","timestamp":1692708546000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/cddis201762"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3,2]]},"references-count":40,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2017,3]]}},"alternative-id":["BFcddis201762"],"URL":"https:\/\/doi.org\/10.1038\/cddis.2017.62","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,3,2]]},"assertion":[{"value":"14 September 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 January 2017","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 January 2017","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 March 2017","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}